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Among the most common non-communicable diseases are obesity, cardiovas-
cular disease, and diabetes, which are responsible for the major cardiometabolic 
phenotypes. Together with mitochondrial alterations, oxidative stress and inflam-
mation are key molecular mechanisms that contribute to the onset and develop-
ment of these conditions. Meal consumption is a recurring daily activity that is 
directly linked to oxidative stress and inflammation. Acute increases in lipids, 
notably triglycerides, during the postabsorptive period have been suggested to 
induce a state of inflammation with stimulation of adhesion molecules, cytokines, 
oxidative stress, and leukocyte activation. Not only lipids but also meal-induced 
elevations in glucose have also been linked to postprandial oxidative stress and 
inflammation. The impact of postprandial hypertriglyceridemia and hypergly-
cemia on oxidative stress and inflammation is not only independent but may be 
cumulative. It is our hypothesis that, in a system that could not maintain homeo-
stasis to continuous changes of the environment, repeated exposures to meals 
that provide modest doses of fat and glucose could potentially elicit abnormal 
responses that contribute to the onset and development of chronic cardiometabolic 
phenotypes.
Keywords: postprandial triglycerides, oxidative stress, inflammation, 
hypertriglyceridemia, hyperglycemia, cardiometabolic phenotypes
1. Introduction
Non-communicable diseases refer to chronic conditions that are non-infectious 
and non-transmissible and include obesity, cardiovascular disease, diabetes, cancer, 
as well as respiratory and neurological diseases. They represent the most common 
cause of death and disability in developed as well as developing countries [1]. In 
addition to age-related mitochondrial alterations, oxidative stress and inflammation 
are key mechanisms in the onset and development of these conditions [2].
Lipids, in particular esterified lipids such as triglycerides (TG), phospholip-
ids, and cholesteryl esters are essential metabolites for energy, cell membrane 
integrity as well as regulatory hormones. Reactive oxygen species (ROS) are 
produced by normal physiological processes and play an important role in cell 
signaling and tissue homeostasis. In view of their high content of polyunsatu-
rated fatty acids (PUFA), lipids transported in plasma lipoproteins as well as 
those in cellular membranes are especially susceptible to ROS damage, i.e. lipid 
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peroxidation. An imbalance between the formation and detoxification of ROS can 
lead to the oxidative stress and the nonenzymatic modification of biomolecules, 
such as proteins, carbohydrates, nucleic acids and lipids. Lipid peroxidation 
damages surface phospholipids directly and delivery of oxidized fatty acids to 
the cells play an important role in many inflammatory diseases and can mediate 
proinflammatory changes [3]. With meal consumption, the intermittent influx of 
newly absorbed dietary fat in the form of TG-rich chylomicrons is associated with 
delayed clearance of plasma lipids. This delay is further exacerbated in individu-
als with metabolic syndrome, type 2 diabetes as well as in obese individuals 
resulting in greater ROS damage.
Chronic hyperglycemia in diabetes is associated with concomitant increase in 
the level of ROS and a reduction in enzymatic and nonenzymatic cell antioxidant 
defenses [4, 5]. In vitro study has demonstrated that intermittent exposure to high 
glucose environment could stimulate superoxide production and enhance endothe-
lial cell apoptosis to a greater extent than exposure to constant high glucose [6]. In 
vivo study also noted that intermittent meal-induced elevations in plasma glucose 
could also play a role in inducing inflammation and oxidative stress [7]. Ingestion 
of glucose has been reported to result in increased production of tumor necrosis 
factor alpha (TNFα) and interleukin-6 (IL-6) by peripheral blood mononuclear 
cells, and increased formation of ROS [8, 9]. Furthermore, addition of glucose to 
a fatty meal delays the metabolism of intestinal chylomicrons in healthy subjects, 
thus enhancing lipid peroxidation. In fact, there is ample evidence that the impact 
of postprandial hyperlipidemia and hyperglycemia on inflammation and oxidative 
stress is independent and cumulative [10].
2. Lipoprotein-associated oxidative stress and inflammation
Oxidative stress refers to an imbalance between the generation of reactive 
oxygen/nitrogen species (ROS/RNS) and the capacity of antioxidative protec-
tion systems to counteract them. All substrates in the cells are potential targets 
of ROS with lipids being most susceptible to undergo oxidative modification, in 
particular polyunsaturated fatty acids (PUFA) with the multiple double bonds [11]. 
Peroxidation of PUFA leads to the formation of isoprostanes [12] and their levels 
are considered to accurately reflect the oxidative status of the environment [13]. 
Oxidative modification of lipids can also result in the formation of reactive alde-
hydes, such as malondialdehyde (MDA) and 4-hydroxynonenal (HNE) [14]. MDA 
and HNE modified metabolites can be detected in plasma [15].
Serving as both a source of energy and structural components of cells, lipids 
are transported in the circulation by a network of globular particles of varying in 
size (from 5 to 1200 nm in diameter) and composition. Independent of the size, 
these so-called lipoproteins consist of a hydrophilic outer layer and a hydrophobic 
inner core [16]. The surface of lipoproteins consists of an amphipathic phospholipid 
bilayer stabilized by non-esterified cholesterol and specific proteins known as 
apolipoproteins. The inner core includes nonpolar lipids such as triglycerides and 
cholesteryl esters in various amounts. The key lipoproteins are the triglyceride-rich 
lipoproteins (TRL), the cholesterol-rich atherogenic lipoproteins, low-density 
lipoproteins (LDL), and the protective, anti-oxidative, anti-atherogenic lipopro-
teins, high-density lipoproteins (HDL). TRL are responsible for the delivery of TG 
to peripheral tissues can be of intestinal origin, chylomicrons, or of hepatic origin, 
very-low density lipoproteins (VLDL). While chylomicrons which carry dietary 
fats are present only in the postprandial state, VLDL are constantly being produced 
by the liver to transport endogenous triglycerides and are metabolic precursors of 
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LDL which are delivered to peripheral tissues as cholesterol-rich particles [16]. In 
addition to their anti-inflammatory and anti-oxidative properties, HDL serves as 
the primary vehicle for reverse cholesterol transport [16].
In the circulation, very-low density lipoproteins (VLDL) are triglyceride-rich 
(TG-rich) lipoproteins synthesized in the liver for the export of new formed TG to 
peripheral tissues [17]. VLDL unloads their cargo of triglycerides via interactions 
with lipoprotein lipase that is anchored to the endothelium via heparan sulfate pro-
teoglycans [18]. As part of this process, lipoprotein particles form tight junction with 
the endothelium allowing released free fatty acids and monoglycerides to be deliv-
ered to the underlying cells. The neutral and oxidized free fatty acids released by the 
hydrolysis of TG-rich lipoproteins can induce endothelial inflammation [19]. In the 
same process, excess ROS generated by activated macrophages in the arterial wall can 
attach themselves to lipoproteins in the circulation (Figure 1). Plasma lipoproteins 
are thus seeded with oxidants that can initiate the propagation of oxidative damage, 
unless the oxidative epitopes are quenched by antioxidant mechanisms [17, 20].
Following meal consumption, newly absorbed dietary fats are packaged in the 
intestine and secreted into the circulation as chylomicrons which contain over 
90% TG by mass and range in diameter from 100 to 1200 nm [16]. These intestine-
derived TG-rich lipoproteins compete with hepatic VLDL for interactions with 
lipoprotein lipase to deliver TG to peripheral tissues. Depending on the TG contents 
in the meal as well as the capacity of the lipolytic system, retention times for both 
VLDL and chylomicrons at the endothelium could be significantly extended. The 
net result is a greater propensity for plasma lipoproteins to be seeded with ROS 
generated in the arterial wall, especially when the endothelium is under chronic 
inflammation. Indeed using immunoassay for IgG specific for oxidative epitopes we 
have reported acute reduction in circulating IgG levels following meal consumption 
in patients with documented coronary artery disease [21]. Furthermore, this tran-
sient reduction was observed only when the meal was enriched in polyunsaturated 
fatty acids which are most susceptible to modification by ROS [22].
With the hydrolysis of VLDL and chylomicron TG to free fatty acids and glyc-
erol, smaller lipoprotein particles are formed relatively enriched in cholesterol, the 
so-called VLDL and chylomicron remnants. While most chylomicron remnants are 
cleared by the liver via receptor-mediated uptake, only 50% of the VLDL remnants 
are directly removed from plasma. The remaining 50% are converted to cholesterol-
rich low-density lipoproteins (LDL), the major cholesterol carrying lipoproteins 
in normal human plasma [23–25]. If the oxidative epitopes transferred from the 
arterial wall to the TG-rich VLDL are not efficiently removed or quenched, we have 
suggested that this could represent an alternate pathway for the formation of oxida-
tively modified LDL (Figure 1) [20]. This is different from the traditional concept 
which postulates that LDL oxidation must take place in the arterial wall [26]. The 
presumption is that plasma lipoprotein lipids are well protected by inherent anti-
oxidant defenses in particular, LDL itself contains most of the antioxidant alpha-
tocopherol in plasma [26]. Recent data would suggest that under certain conditions, 
oxidative modification of plasma lipoproteins could be initiated in the circulation. 
By using the in vitro assay described by Esterbauer et al. [27] to assess the oxidative 
susceptibility of plasma LDL, we can show that, while LDL isolated from fasting 
plasma would undergo oxidative modification only in the presence of Cu++ as a cata-
lyst, LDL isolated from non-fasting plasma was susceptible to auto-oxidation in the 
absence of Cu++ (Figure 2A) [28]. Furthermore, in some patients with metabolic 
syndrome, auto-oxidation of fasting LDL could be prevented following manage-
ment with ABT-335 (choline salt of fenofibric acid) (Figure 2B) [28].
While endothelial cells are continuously exposed to high concentrations of 
free fatty acids in the fasted state generated by the hydrolysis of hepatic VLDL, 
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intermittent entries of intestinal chylomicrons carrying dietary fats can further 
increase this concentration. Depending on the type of fat, interactions of these free 
fatty acids with endothelial cells could have deleterious effect on endothelial func-
tion [29, 30]. In vitro studies with human aortic endothelial cells have demonstrated 
that high levels of the polyunsaturated fatty acid linoleic acid increase endothelial 
cell permeability [31] whereas increased levels of the saturated fatty acid palmi-
tate and the monounsaturated fatty acid oleate tend to decrease the activity of 
Figure 1. 
Interactions of TG-rich lipoproteins with the endothelium. (A) In the case of the healthy endothelium, as 
TG-rich lipoproteins (TRL) are attached to the arterial wall via heparan sulfate proteoglycans, lipoprotein 
lipase (LPL) hydrolyzes TG into free fatty acids (FA) and monoglycerides that can penetrate the endothelium 
and be reconstitute as stored TG. With modest quantity of activated macrophages, only minimal amount 
of ROS is generated to seed plasma lipoproteins. In the circulation, lipoproteins undergo remodeling via the 
action of phospholipid lipid transfer protein (PLTP) and cholesteryl ester transfer protein (CETP) with the 
transfer of oxidized lipids to high-density lipoproteins (HDL) where they are inactivated by antioxidant 
enzymes, including paraoxonase (PON-1), lipoprotein-associated phospholipase A2 (Lp-PLA2) and 
glutathione peroxidase (GPx-1). With the depletion of TG, TG-rich lipoproteins are converted to normal 
chylomicron remnants and LDL. (B) In the case of the inflamed endothelium, there are excess generation of 
ROS by increasing number of activated macrophages. Together with impaired hydrolysis by LPL and greater 
flux of TG-rich lipoproteins, the retention time of TRL along the arterial wall is increased resulting to a 
greater opportunity for ROS to seed plasma lipoproteins. In the circulation, while oxidized lipids may still be 
transferred to HDL, the antioxidative properties of HDL have been reduced. The net result is the generation of 
chylomicron remnants and LDL with significant number of oxidative epitopes that could undergo spontaneous 
auto-oxidation.
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endothelial nitric oxide synthase [32]. However, if these newly released free fatty 
acids have been previously oxidized, they can elicit additional pro-inflammatory 
responses in endothelial cells. Oxidized free fatty acids can have direct effect on 
toll-like receptors, insulin resistance, upregulation of NF-κB, expression of adhe-
sion molecules and macrophage cytotoxicity [33, 34].
In addition to the free fatty acids released as part of the hydrolysis of TG-rich 
lipoproteins, LDL is direct product of the metabolism of TG-rich VLDL [17]. The 
presence of oxidized phospholipids on the surface of plasma lipoproteins can also 
contribute to oxidative and inflammatory status [35–37]. As illustrated (Figure 1), 
a number of intrinsic enzymes on circulating HDL can blunt the deleterious effect 
of oxidized phospholipids, namely paraoxonase-1, lipoprotein-associated phospho-
lipase A2 and glutathione peroxidase-1 [38]. However, in individuals with hypertri-
glyceridemia, excess generation of LDL with oxidized phospholipids [26, 39] and 
impaired anti-oxidant enzymes on HDL may exacerbate the oxidative process.
3. Glucose-associated oxidative stress and inflammation
Exposure to elevated plasma glucose in patients with type 2 diabetes mellitus is 
associated with both an increased level of ROS and a drop in cell antioxidant defense, 
enzymatic as well as non-enzymatic [4, 5]. In addition to serving as a barrier to con-
trol movements of fluid, solutes and cells between blood and tissue, the endothelial 
layer also play a key role in regulating vascular tone and inflammatory processes [40]. 
While the impact of hyperglycemia on endothelial cell metabolism is beyond the 
scope of this presentation it should be noted that, at normal fasting plasma glucose 
concentrations (4–6 mM, 72–108 mg/dL), the glucose transporter GLUT-1 is already 
functioning at saturation level [41]. GLUT-1 is the primary glucose carrier respon-
sible for the uptake of glucose by endothelial cells [42]. In vitro studies with human 
umbilical vein endothelial cells have indicated that exposure to high concentration of 
glucose is associated with increased oxidative stress as assessed by increased levels of 
nitrotyrosine and 8-hydroxy-2′-deoxyguanosine [6]. In fact, the increase in oxidative 
stress was even more pronounced when endothelial cells were exposed intermittently 
to high and low glucose concentrations [6]. It has also been demonstrated that high 
Figure 2. 
Continuous monitoring of in vitro oxidation of LDL from two patients with metabolic syndrome. (A) In the 
absence of the catalyst Cu++, LDL isolated from Patient A at 4 h after meal undergoes spontaneous auto-
oxidation while LDL isolated from fasting plasma does not. (B) During the placebo period, fasting LDL 
isolated from Patient B undergoes spontaneous auto-oxidation in the absence of Cu++ and the lag time is 
significantly reduced in the presence of Cu++. (C) After 8 weeks of therapy with ABT-335, fasting LDL from 
Patient B no longer undergoes auto-oxidation in the absence of Cu++ and demonstrates the typical oxidation 
kinetics in the presence of Cu++.
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glucose levels stimulate ROS production through protein kinase C (PKC)-dependent 
activation of NAD(P)H oxidase [43, 44]. The net result of constant and intermittent 
hyperglycemia is enhancement of endothelial cell apoptosis [6, 44].
In both normal and type 2 diabetic patients, intermittent hyperglycemia has 
been demonstrated to be more deleterious to endothelial cell metabolism and 
oxidative stress than constant elevations in plasma glucose [45]. In fact, reduction in 
the mean amplitude of glycemic excursion with dipeptidyl peptidase-IV inhibition 
in patients with type 2 diabetes is associated with reduction in oxidative stress and 
biomarkers of inflammation [46].
In addition to the stimulation of ROS production, exposure to high glucose 
concentrations can also lead to nonenzymatic modifications of proteins with the 
formation of glycated proteins or advanced glycation end-products (AGE) [47]. 
Glycation of specific proteins can severely alter their function as in the case of gly-
cated hemoglobin C with increased affinity for oxygen and subsequent decreased 
oxygen delivery to tissues [48]. Glycation of plasma LDL by methylglyoxal, a side 
product of glycolysis, results in enhanced delivery of these pro-atherogenic particles 
to the arterial wall leading to increased risk for atherosclerosis in patients with type 
2 diabetes [49]. Glycation of insulin has also been suggested to contribute to insulin 
resistance leading to more severe hyperglycemia [50].
4. Meal-induced oxidative stress and inflammation
The fat content of a typical Western meal ranges from 20 to 40 g of fat which 
corresponds to between 5 and 8 times the total pool of TG in plasma. In a healthy 
individual with normal metabolism, plasma TG level reaches peak level by 2 h 
after meal and returns to pre-meal level by 6 h. As many individuals customarily 
consume 3 meals a day, they spend the majority of their day in the postprandial 
state. Several processes contribute to the increased oxidative stress and inflamma-
tory state associated with meal consumption [51]. The magnitude and timing of 
postprandial inflammatory response to a high-fat meal may depend on fat content, 
caloric intake, body-mass index [52] as well as age of the individual [53, 54].
Firstly, as noted in earlier section, the intermittent secretion of intestinal 
chylomicrons after each meal has a direct effect on the metabolism of circulating 
hepatic VLDL. While this may not be the case for individuals with normal TG 
levels, the lipolytic system may be saturated in individuals with elevated TG as in 
the case of obesity and diabetes. The net result is a delayed clearance of TG-rich 
lipoproteins, prolonged interactions of TG-rich particles with the endothelium, and 
greater potential for the transfer of ROS from the arterial wall to circulating plasma 
lipoproteins (Figure 1B). Treatment of peripheral blood mononuclear cells with 
lipolysis products of postprandial TG-rich lipoproteins resulted in increased expres-
sion of TNFa, IL-1b, and IL-8 [55].
Secondly, the meal-induced change in free fatty acids can contribute to the 
deleterious impact on the endothelium not only with respect to the increased in 
concentrations but also to the type of free fatty acids. In patients with insulin 
resistance, the impact of postprandial free fatty acids is further exacerbated by the 
failure of postprandial insulin to inhibit the activity of hormone-sensitive lipase 
(HSL) in tissues. In the normal individuals, the increase in insulin concentration 
during postprandial lipemia would inhibit the activity of HSL and shut off the 
mobilization of free fatty acids from peripheral tissues [56–58]. With insulin resis-
tance, HSL remains active during postprandial lipemia and continues to mobilize 
free fatty acids from intracellular stores contributing to even higher plasma free 
fatty acid concentrations.
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Thirdly and most importantly is the independent and cumulative effect of 
postprandial hypertriglyceridemia and hyperglycemia on oxidative stress and 
inflammation [10]. In both normal and diabetic individuals, compared to high fat 
meal, the inclusion of a glucose dose equivalent to an oral glucose tolerance test 
resulted in greater increase in nitrotyrosine and circulating adhesion molecules, 
including E-selectin, ICAM-1, and VCAM-1 [59]. Management with simvastatin in 
the short term (3 days) did not affect lipids but reduced the effect on nitrotyrosine 
and adhesion molecules. Extended therapy with simvastatin (3 months) blunted 
the meal-induced hypertriglyceridemia as well as the post-prandial responses in 
nitrotyrosine and adhesion molecules [10, 59]. In patients with type 2 diabetes, 
meal-induced increases in TG and glucose were attenuated by prandial + basal 
insulin [60]. Post-meal increased in C-reactive protein (hs-CRP), IL-6, and TNFa 
were also reduced [60] with the addition of prandial insulin.
5. Future directions
In view of the fact that individuals are in a postprandial state throughout the 
day, assessment of oxidative and inflammatory status in the fasted might not 
provide an accurate snapshot. It is important to understand the processes that affect 
oxidative stress and inflammatory status in a non-fasted state [61]. Additional 
research is needed to understand how nutrients, with respect to quality, quantity, 
and frequency, could be managed to attenuate the deleterious effect of postprandial 
hypertriglyceridemia and hyperglycemia on oxidative stress and inflammation [62]. 
Blunting the acute daily fluctuations in plasma glucose and triglycerides may be a 
novel mode of management to reduce oxidative stress and inflammation in high-
risk individuals. Furthermore, special attention should be placed on the timing of 
antioxidant ingestion in relation to meal consumption as that might have a direct 
impact on the time course of postprandial response [63].
6. Conclusions
Assessment of oxidative and inflammatory status in the fasted state may not 
provide an accurate picture of the metabolic status of an individual. Intermittent 
elevations in plasma triglycerides and glucose associated with meal consumption 
throughout the day may be associated with considerable increase in oxidative stress 
and inflammation depending on the quantity and quality of the meals.
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